Results 181 to 190 of about 119,472 (328)

In Situ/Operando Probing of Dynamic Phase Structures of Alumina‐Supported Ultrasmall Copper‐Gold Alloy Nanoparticles Under Reaction Conditions

open access: yesAngewandte Chemie, EarlyView.
Supported ultrasmall copper‐gold alloy nanoparticles are active heterogenous catalysts. In situ TEM tracking under oxygen at different temperatures reveals atomic‐scale dynamic phase structures, whereas combined operando synchrotron HE‐XRD and DRIFTS characterizations uncover ensemble‐averaged ordering/disordering phase structures and oscillatory ...
Han‐Wen Cheng   +16 more
wiley   +2 more sources

AI in Neurology: Everything, Everywhere, All at Once Part 1: Principles and Practice

open access: yesAnnals of Neurology, EarlyView.
Artificial intelligence (AI) is rapidly transforming healthcare, yet it often remains opaque to clinicians, scientists, and patients alike. This review, part 1 of a 3‐part series, provides neurologists and neuroscientists with a foundational understanding of AI's key concepts, terminology, and applications.
Matthew Rizzo, Jeffrey D. Dawson
wiley   +1 more source

AI in Neurology: Everything, Everywhere, all at Once PART 2: Speech, Sentience, Scruples, and Service

open access: yesAnnals of Neurology, EarlyView.
Artificial intelligence (AI) applications are finding use in real‐world neurological settings. Whereas part 1 of this 3‐part review series focused on the birth of AI and its foundational principles, this part 2 review shifts gears to explore more practical aspects of neurological care.
Matthew Rizzo
wiley   +1 more source

Progress in Biomimetic Microdevices for Anticancer Drug Screening and their Potential for Enhancing In Vivo Efficacy

open access: yesAdvanced NanoBiomed Research, EarlyView.
Biomimetic microdevices are redefining anticancer drug screening by mimicking complex tumor microenvironments. This review highlights advances in microfluidic systems, cell microarrays, and in vivo‐like models, offering new insights into drug efficacy prediction and personalized medicine. The development of effective anticancer drugs remains a critical
Ching‐Te Kuo   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy